73 related articles for article (PubMed ID: 26214555)
1. Low-Dose Fluvastatin and Valsartan Rejuvenate the Arterial Wall Through Telomerase Activity Increase in Middle-Aged Men.
Janić M; Lunder M; Cerkovnik P; Prosenc Zmrzljak U; Novaković S; Šabovič M
Rejuvenation Res; 2016 Apr; 19(2):115-9. PubMed ID: 26214555
[TBL] [Abstract][Full Text] [Related]
2. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
[TBL] [Abstract][Full Text] [Related]
3. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
4. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
5. Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat "Aging-Related Disorders".
Janić M; Lunder M; Novaković S; Škerl P; Šabovič M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013989
[TBL] [Abstract][Full Text] [Related]
6. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
7. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
8. Improvement of arterial wall phenotype in subjects at moderate cardiovascular risk induced by very low-dose fluvastatin/valsartan combination: a pilot study.
Turk Veselič M; Žorž N; Eržen B; Škerl P; Novaković S; Janić M; Šabovič M
Int Angiol; 2018 Oct; 37(5):356-364. PubMed ID: 29952159
[TBL] [Abstract][Full Text] [Related]
9. A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age.
Janić M; Lunder M; Šabovič M
Biomed Res Int; 2015; 2015():235709. PubMed ID: 25821790
[TBL] [Abstract][Full Text] [Related]
10. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
[TBL] [Abstract][Full Text] [Related]
11. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
12. Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot study.
Lunder M; Janić M; Habjan S; Sabovič M
Atherosclerosis; 2011 Apr; 215(2):446-51. PubMed ID: 21300350
[TBL] [Abstract][Full Text] [Related]
13. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin remodels resistance arteries in genetically hypertensive rats, even in the absence of any effect on blood pressure.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):931-4. PubMed ID: 12207574
[TBL] [Abstract][Full Text] [Related]
15. Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study.
Turk Veselič M; Eržen B; Hanžel J; Piletič Ž; Šabovič M
Med Sci Monit; 2018 Sep; 24():6892-6899. PubMed ID: 30266894
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.
Li Z; Iwai M; Wu L; Liu HW; Chen R; Jinno T; Suzuki J; Tsuda M; Gao XY; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 Nov; 44(5):758-63. PubMed ID: 15452025
[TBL] [Abstract][Full Text] [Related]
17. Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.
Westphal S; Abletshauser C; Luley C
Coron Artery Dis; 2009 Jan; 20(1):81-5. PubMed ID: 19060628
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
19. Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats.
Cumaoğlu A; Ozansoy G; Irat AM; Arıcıoğlu A; Karasu C; Arı N
Eur J Pharmacol; 2011 Mar; 654(1):80-5. PubMed ID: 21172345
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin reduces oxidative stress, decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia.
Leu HB; Wu CC; Wu TC; Lin SJ; Chen JW
J Formos Med Assoc; 2004 Dec; 103(12):914-20. PubMed ID: 15624040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
